Registered outcomes54

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 20 of 54

List	Outcome	Time frame
Primary	TAK-875 maximum observed plasma concentration (Cmax)	Day 14
Primary	TAK-875 time at which Cmax occurred (Tmax)	Day 14
Primary	TAK-875 area under the plasma concentration-time curve from time 0 to time tau, where tau is the length of a dosing interval AUC(0-tau)	Day 14
Primary	TAK-875 renal clearance (CLr)	Day 14
Primary	TAK-875 metabolite (M-I) Cmax	Day 14
Primary	TAK-875 M-I Tmax	Day 14
Primary	TAK-875 M-I AUC(0-tau)	Day 14
Primary	TAK-875 M-I renal clearance CLr	Day 14
Secondary	TAK-875 Cmax	Day 1
Secondary	TAK-875 Tmax	Day 1
Secondary	TAK-875 AUC(0-tau)	Day 1
Secondary	TAK-875 renal clearance CLr	Day 1
Secondary	M-I Tmax	Day 1
Secondary	M-I Cmax	Day 1
Secondary	M-I AUC(0-tau)	Day 1
Secondary	M-I renal clearance CLr	Day 1
Secondary	TAK-875 and M-I Cmax ratio	Day 1
Secondary	TAK-875 and M-I Cmax ratio	Day 14
Secondary	TAK-875 and M-I AUC(0-tau) ratio	Day 1
Secondary	TAK-875 and M-I AUC(0-tau) ratio	Day 14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00949091/registered